세계의 해양 바이오테크놀러지 시장 : 제품, 공급원, 기술, 용도, 최종 이용 산업별 예측(2025-2030년)

The Marine Biotechnology Market was valued at USD 30.64 billion in 2023, expected to reach USD 32.85 billion in 2024, and is projected to grow at a CAGR of 8.87%, to USD 55.59 billion by 2030.

Marine biotechnology involves the application of scientific and engineering principles to understand and utilize marine organisms and resources for various industrial, pharmaceutical, agricultural, and environmental purposes. It encompasses the study of marine ecosystems, marine-derived drugs, bioremediation using marine organisms, biofuels, and aquaculture advancements. The necessity of marine biotechnology stems from the vast potential it holds in addressing global challenges such as food security, sustainable energy, and health. With unique compounds derived from marine organisms showing promise in drug development, it offers alternative resources for industries aiming to reduce the environmental footprint while creating value. Applications span across pharmaceuticals (anticancer, anti-inflammatory drugs), cosmetics, nutraceuticals, and biofuel production. End-use industries such as healthcare, cosmetics, agriculture, and aquaculture are primary beneficiaries.

Key growth factors include increasing interest in sustainable production methods, technological advancements in genomics and proteomics, and rising awareness of the economic and environmental advantages of marine bioproducts. Potential opportunities involve the discovery of novel compounds and bioprocesses, driven by advances in genetic research and bioinformatics. Markets like North America and Europe, which prioritize green technologies, present lucrative opportunities for marine biotechnology innovation. However, challenges such as high research costs, ecological concerns, and stringent regulatory frameworks act as significant barriers. Intellectual property rights concerning marine genetic resources also pose bottlenecks. Innovation areas include the development of eco-friendly aquaculture technology, marine-derived pharmaceuticals, and microbial fuel applications.

Research efforts could focus on enhancing extraction and processing techniques to improve yield and reduce costs. Entering strategic partnerships and increasing investment in R&D are recommended approaches to seize emerging opportunities. The market is dynamic, characterized by rapid technological advancements and evolving regulations, necessitating agility and continuous innovation from businesses to stay competitive. Firms can benefit from diversifying their portfolios and fostering collaborations with research institutions to harness the full potential of marine biotechnology effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Marine Biotechnology Market

The Marine Biotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use of marine ingredients in food, agriculture, and cosmetic industries
  • Rising need for drug discovery, fisheries, and aquaculture
  • Growing use of marine algae & microalgae for biofuel production
• Market Restraints
  • Lack of exploration in oceans
• Market Opportunities
  • Advances in marine biotechnology to develop completely new class of biodegradable biopolymers
  • Increasing emphasis on marine technology and huge investments in marine research centers
• Market Challenges
  • Concerns associated with legal and regulatory barriers

Porter's Five Forces: A Strategic Tool for Navigating the Marine Biotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Marine Biotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Marine Biotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Marine Biotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Marine Biotechnology Market

A detailed market share analysis in the Marine Biotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Marine Biotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Marine Biotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Marine Biotechnology Market

A strategic analysis of the Marine Biotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Marine Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, Biolchim Group by J.M. Huber Corporation, BioLume, Earthrise Nutritionals LLC, GeoMarine Biotechnologies (P) LTD, GlycoMar Ltd., Marinova Pty Ltd, Marshall Marine Products, Nofima, oceanBASIS GmbH, Pharma Mar, S.A., Plymouth Marine Laboratory, PROLUME, LTD, Royal DSM N.V., and Seppic S.A..

Market Segmentation & Coverage

This research report categorizes the Marine Biotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bio Active Substances and Bio Material.
• Based on Source, market is studied across Corals & Sponges, Marine Algae, Marine Fungi, and Marine Viruses.
• Based on Technology, market is studied across Culture-Independent Techniques and Isolation & Cultivation of Microorganisms.
• Based on Application, market is studied across Aquaculture & Fishery, Biofuels, Drug Discovery, Environmental Health & Human Health, Food supply, and Industrial Products & Processes.
• Based on End-use industry, market is studied across Chemical, Cosmetics, Energy, Food Industry, and Medical & Pharmaceutical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of marine ingredients in food, agriculture, and cosmetic industries
    • 5.1.1.2. Rising need for drug discovery, fisheries, and aquaculture
    • 5.1.1.3. Growing use of marine algae & microalgae for biofuel production
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of exploration in oceans
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in marine biotechnology to develop completely new class of biodegradable biopolymers
    • 5.1.3.2. Increasing emphasis on marine technology and huge investments in marine research centers
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with legal and regulatory barriers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Marine Biotechnology Market, by Product

• 6.1. Introduction
• 6.2. Bio Active Substances
• 6.3. Bio Material

7. Marine Biotechnology Market, by Source

• 7.1. Introduction
• 7.2. Corals & Sponges
• 7.3. Marine Algae
• 7.4. Marine Fungi
• 7.5. Marine Viruses

8. Marine Biotechnology Market, by Technology

• 8.1. Introduction
• 8.2. Culture-Independent Techniques
• 8.3. Isolation & Cultivation of Microorganisms

9. Marine Biotechnology Market, by Application

• 9.1. Introduction
• 9.2. Aquaculture & Fishery
• 9.3. Biofuels
• 9.4. Drug Discovery
• 9.5. Environmental Health & Human Health
• 9.6. Food supply
• 9.7. Industrial Products & Processes

10. Marine Biotechnology Market, by End-use industry

• 10.1. Introduction
• 10.2. Chemical
• 10.3. Cosmetics
• 10.4. Energy
• 10.5. Food Industry
• 10.6. Medical & Pharmaceutical

11. Americas Marine Biotechnology Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Marine Biotechnology Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Marine Biotechnology Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aker BioMarine ASA
• 2. Biolchim Group by J.M. Huber Corporation
• 3. BioLume
• 4. Earthrise Nutritionals LLC
• 5. GeoMarine Biotechnologies (P) LTD
• 6. GlycoMar Ltd.
• 7. Marinova Pty Ltd
• 8. Marshall Marine Products
• 9. Nofima
• 10. oceanBASIS GmbH
• 11. Pharma Mar, S.A.
• 12. Plymouth Marine Laboratory
• 13. PROLUME, LTD
• 14. Royal DSM N.V.
• 15. Seppic S.A.